Bacil Pharma Ltd.
| BSE: 524516 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE711D01018 |
| BSE 00:00 | 13 Apr | 3.96 |
0 (0.00%) |
OPEN
3.96 |
HIGH
3.96 |
LOW
3.95 |
| NSE 05:30 | 01 Jan | Bacil Pharma Ltd |
| OPEN | 3.96 |
| PREVIOUS CLOSE | 3.96 |
| VOLUME | 809 |
| 52-Week high | 6.12 |
| 52-Week low | 1.57 |
| P/E | |
| Mkt Cap.(Rs cr) | 2 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bacil Pharma Ltd. (BACILPHARMA) - Financial Overview
Particulars ( cr) |
2020 | 2019 | 2018 |
| Net Sales | 0.00 | 0.00 | 0.00 |
| Operating Profit | -0.30 | -0.33 | -3.71 |
| Other Income | 0.14 | 0.09 | 0.27 |
| Interest | 0.01 | 0.00 | 0.03 |
| Depreciation | 0.01 | 0.01 | 0.01 |
| Profit Before Tax | -0.32 | -0.34 | -3.75 |
| Tax | 0.00 | 0.00 | 0.00 |
| Profit After Tax | -0.32 | -0.34 | -3.75 |
| Share Capital | 6.53 | 6.53 | 6.53 |
| Reserves | -5.14 | -4.62 | -4.29 |
| Net Worth | 1.39 | 1.91 | 2.24 |
| Loans | 0.17 | 0.10 | 0.00 |
| Gross Block | 2.56 | 2.56 | 2.56 |
| Investments | 0.43 | 0.96 | 1.15 |
| Cash | 0.04 | 0.09 | 0.27 |
| Debtors | 0.00 | 0.00 | 0.01 |
| Net Working Capital | -1.40 | -1.48 | -1.46 |
| Operating Profit Margin (%) | |||
| Net Profit Margin (%) | |||
| Earning Per Share (Rs) | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 |
| Dividend Payout | 0.00 | 0.00 | 0.00 |
Quick Links for Bacil Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
